{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:14:58Z","timestamp":1784664898839,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ophtha.2014.09.034","type":"journal-article","created":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T07:36:32Z","timestamp":1416296192000},"page":"555-561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"title":["One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy"],"prefix":"10.1016","volume":"122","author":[{"given":"Kyoko","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1543-9345","authenticated-orcid":false,"given":"Kei","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Soiti","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouhei","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Yuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.ophtha.2014.09.034_bib1","first-page":"1","article-title":"Pathogenesis of disciform detachment of the neuroepithelium","volume":"63","author":"Gass","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","article-title":"Indocyanine green videoangiography of older patients with central serous chorioretinopathy","volume":"16","author":"Spaide","year":"1996","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(14)70531-8","article-title":"Choroidal capillary and venous congestion in central serous chorioretinopathy","volume":"121","author":"Pr\u00fcnte","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib4","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","article-title":"Subfoveal choroidal thickness after treatment of central serous chorioretinopathy","volume":"117","author":"Maruko","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.09.034_bib6","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0161-6420(84)34095-7","article-title":"Retinal pigment epithelium decompensation. I. Clinical features and natural course","volume":"91","author":"Jalkh","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.09.034_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bjo.77.6.349","article-title":"Subretinal exudative deposits in central serous chorioretinopathy","volume":"77","author":"Ie","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-200302000-00001","article-title":"Cystoid macular degeneration in chronic central serous chorioretinopathy","volume":"23","author":"Iida","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib9","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.ophtha.2010.08.017","article-title":"Fundus autofluorescence and visual acuity in central serous chorioretinopathy","volume":"118","author":"Imamura","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.09.034_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00006982-200312000-00002","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"23","author":"Cardillo Piccolino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","article-title":"Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study","volume":"23","author":"Yannuzzi","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00417-009-1104-8","article-title":"Prognostic factors related to photodynamic therapy for central serous chorioretinopathy","volume":"247","author":"Moon","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10384-008-0613-z","article-title":"Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy","volume":"53","author":"Lee","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","article-title":"Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level","volume":"87","author":"Chan","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IAE.0b013e318156777f","article-title":"Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study","volume":"28","author":"Chan","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/bjo.2006.090282","article-title":"Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study","volume":"90","author":"Lai","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ajo.2010.08.019","article-title":"Microperimetric changes after photodynamic therapy for central serous chorioretinopathy","volume":"151","author":"Senturk","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5301\/ejo.5000051","article-title":"Long-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"22","author":"Rouvas","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","article-title":"Association between the efficacy of half-dose photodynamic therapy with\u00a0indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy","volume":"153","author":"Nicol\u00f2","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/eye.2013.24","article-title":"Long-term results of half-dose photodynamic therapy for chronic central serous chorioretinopathy with contrast sensitivity changes","volume":"27","author":"Karakus","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.09.034_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajo.2014.01.022","article-title":"Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy","volume":"157","author":"Nicol\u00f2","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ajo.2009.08.026","article-title":"Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial","volume":"149","author":"Reibaldi","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib23","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00417-013-2289-4","article-title":"One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis","volume":"251","author":"Ohkuma","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/eye.2013.13","article-title":"Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy","volume":"27","author":"Lim","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.09.034_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/IAE.0b013e318280769c","article-title":"Half-fluence photodynamic therapy in chronic central serous chorioretinopathy","volume":"33","author":"Smretschnig","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/eye.2012.273","article-title":"Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy","volume":"27","author":"Kang","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2014.09.034_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ajo.2009.10.011","article-title":"Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy","volume":"149","author":"Inoue","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1755-3768.2008.01408.x","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy","volume":"88","author":"Ruiz-Moreno","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/IAE.0b013e3181e378f2","article-title":"Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00417-011-1900-9","article-title":"Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy","volume":"250","author":"Copete","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/IAE.0b013e3182618bc5","article-title":"Foveal function and thickness after verteporfin photodynamic therapy in central serous chorioretinopathy with hyperautofluorescent subretinal deposits","volume":"33","author":"Pryds","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/IAE.0b013e3182670fbe","article-title":"Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study","volume":"33","author":"Silva","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ajo.2012.05.001","article-title":"Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability","volume":"154","author":"Goto","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib34","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/IAE.0000000000000027","article-title":"Quantification of metamorphopsia in chronic central serous chorioretinopathy after half-dose verteporfin photodynamic therapy","volume":"34","author":"Fujita","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2014.09.034_bib35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2013.11.040","article-title":"Collaborative Retrospective Macula Society study of photodynamic therapy for chronic central serous chorioretinopathy","volume":"121","author":"Lim","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.09.034_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3341\/kjo.2012.26.1.15","article-title":"Clinical characteristics of polypoidal choroidal vasculopathy associated with chronic central serous\u00a0chorioretionopathy","volume":"26","author":"Park","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0161-6420(99)00173-6","article-title":"Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy","volume":"107","author":"Yannuzzi","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2014.09.034_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ajo.2012.07.018","article-title":"Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability","volume":"155","author":"Koizumi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archophthalmol.2011.148","article-title":"The expanded spectrum of focal choroidal excavation","volume":"129","author":"Margolis","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2014.09.034_bib40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajo.2013.05.010","article-title":"Focal choroidal excavation in eyes with central serous chorioretinopathy","volume":"156","author":"Ellabban","year":"2013","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014009397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642014009397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:05:34Z","timestamp":1758981934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642014009397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0161642014009397"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.09.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725255723.793524183","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One-Year Outcomes with Half-Dose Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2014.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}